Sebia reagents and services

The Department of Health, Bureau of Public Health Laboratories (BPHL), Newborn Screening Unit is seeking to purchase reagents, controls, calibrators, consumables, and services for the FDA-approved CAPILLARS 3 DBS automated analyzer. This equipment is used for qualitative screening for the detection of normal hemoglobin and abnormal hemoglobin using dry blood from human newborns. The contract will be for a period of three years. • The contract is for the purchase of reagents, controls, calibrators, consumables, and services for the CAPILLARS 3 DBS automated analyzer. • The equipment is used for newborn screening. • The contract period is three years. • The estimated dollar amount for the contract is $2,695,571.00.